1. |
李彬, 孙宪丽, 郑邦和, 等. 52例睫状体占位性病变的组织来源、临床特征及组织病理学分析[J]. 中华眼科杂志, 2000, 36(4): 250-254. DOI: 10.3760/j:issn:0412-4081.2000.04.003.Li B, Sun XL, Zheng BH, et al. The histogenesis, clinical features and histopathological analysis on 52 cases of ciliary body neoplasms[J]. Chin J Ophthalmol, 2000, 36(4): 250-254. DOI: 10.3760/j:issn:0412-4081.2000.04.003.
|
2. |
Kaliki S, Shields CL, Eagle RC Jr, et al. Ciliary body medulloepithelioma: analysis of 41 cases[J]. Ophthalmology, 2013, 120(12): 2552-2559. DOI: 10.1016/j.ophtha.2013.05.015.
|
3. |
Sansgiri RK, Wilson M, McCarville MB, et al. Imaging features of medulloepithelioma: report of four cases and review of the literature[J]. Pediatr Radiol, 2013, 43(10): 1344-1356. DOI: 10.1007/s00247-013-2718-x.
|
4. |
Broughton WL, Zimmerman LE. A clinicopathologic study of 56 cases of intraocular medulloepitheliomas[J]. Am J Ophthalmol, 1978, 85(3): 407-418. DOI: 10.1016/s0002-9394(14)77739-6.
|
5. |
Verdijk RM. On the classification and grading of medulloepithelioma of the eye[J]. Ocul Oncol Pathol, 2016, 2(3): 190-193. DOI: 10.1159/000443963.
|
6. |
Laver NV, McLaughlin ME, Duker JS. Ocular melanoma[J]. Arch Pathol Lab Med, 2010, 134(12): 1778-1784. DOI: 10.5858/2009-0441-rar.1.
|
7. |
Demirci H, Shields CL, Shields JA, et al. Ring melanoma of the ciliary body: report on twenty-three patients[J]. Retina, 2002, 22(6): 698-706. DOI: 10.1097/00006982-200212000-00003.
|
8. |
Costache M, Patrascu OM, Adrian D, et al. Ciliary body melanoma - a particularly rare type of ocular tumor. Case report and general considerations[J]. Maedica (Bucur), 2013, 8(4): 360-364.
|
9. |
Zhang Z, Li B, Shi J, et al. Intraocular extension of conjunctival squamous cell carcinoma[J]. Ophthalmologica, 2007, 221(3): 200-203. DOI: 10.1159/000099302.
|
10. |
McKelvie PA, Daniell M, McNab A, et al. Squamous cell carcinoma of the conjunctiva: a series of 26 cases[J]. Br J Ophthalmol, 2002, 86(2): 168-173. DOI: 10.1136/bjo.86.2.168.
|
11. |
Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva[J]. Br J Cancer, 1996, 74(10): 1511-1513. DOI: 10.1038/bjc.1996.581.
|
12. |
Yan J, Liu X, Zhang P, et al. Acquired adenoma of the nonpigmented ciliary epithelium: analysis of five cases[J]. Graefe's Arch Clin Exp Ophthalmol, 2015, 253(4): 637-644. DOI: 10.1007/s00417-014-2928-4.
|
13. |
Chen ZQ, Fang XY. Adenoma of nonpigmented epithelium in ciliary body: literature review and case report[J]. J Zhejiang Univ Sci B, 2007, 8(9): 612-615. DOI: 10.1631/jzus.2007.B0612.
|
14. |
Tomar AS, Finger PT, Iacob CE. Intraocular leiomyoma: current concepts[J]. Surv Ophthalmol, 2020, 65(4): 421-437. DOI: 10.1016/j.survophthal.2019.12.008.
|
15. |
Blodi FC. Leiomyoma of the ciliary body[J]. Am J Ophthalmol, 1950, 33(6): 939-942. DOI: 10.1016/0002-9394(50)91612-6.
|
16. |
Biswas J, Kumar SK, Gopal L, et al. Leiomyoma of the ciliary body extending to the anterior chamber: clinicopathologic and ultrasound biomicroscopic correlation[J]. Surv Ophthalmol, 2000, 44(4): 336-342. DOI: 10.1016/s0039-6257(99)00114-9.
|
17. |
El Mokh H, Ben Yahia N, Bouziri M, et al. Ciliary body schwannoma: a case report and literature review[J]. J Ophthalmic Vis Res, 2022, 17(4): 581-586. DOI: 10.18502/jovr.v17i4.12339.
|
18. |
Yu Y, Cheng Y, Wang K, et al. Intraocular schwannoma: a case series of 3 patients[J]. Oncol Lett, 2019, 17(1): 1274-1278. DOI: 10.3892/ol.2018.9718.
|
19. |
Goto H, Yamakawa N, Tsubota K, et al. Clinicopathologic analysis of 32 ciliary body tumors[J]. Jpn J Ophthalmol, 2021, 65(2): 237-249. DOI: 10.1007/s10384-021-00814-y.
|
20. |
Gündüz AK, Mirzayev I. Surgical approach in intraocular tumors[J]. Turk J Ophthalmol, 2022, 52(2): 125-138. DOI: 10.4274/tjo.galenos.2021.24376.
|
21. |
Tadepalli SH, Shields CL, Shields JA, et al. Intraocular medulloepithelioma-a review of clinical features, DICER 1 mutation, and management[J]. Indian J Ophthalmol, 2019, 67(6): 755-762. DOI: 10.4103/ijo.IJO_845_19.
|
22. |
Simpson ER. Ciliary body melanoma: a special challenge[J]. Can J Ophthalmol, 2004, 39(4): 365-371. DOI: 10.1016/s0008-4182(04)80007-3.
|